N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
C40H42N12O8 — CID 155063820
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 155063820) has the molecular formula C40H42N12O8 and a molecular weight of 818.85 g/mol. Its IUPAC name is N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 155063820 |
| Molecular Formula | C40H42N12O8 |
| Molecular Weight | 818.85 g/mol |
| Exact Mass | 818.32 |
| IUPAC Name | N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-furo[2,3-b]pyridin-5-yl]-2-[4-[(2S)-2-(hydroxymethyl)-2-methyl-5-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)-3H-furo[2,3-b]pyridin-6-yl]morpholin-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | C[C@@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOC(c4nn5cccnc5c4C(=O)Nc4cc5c(nc4N4CCOCC4)O[C@@](C)(CO)C5)C3)nc2O1 |
| InChI | InChI=1S/C40H42N12O8/c1-39(21-53)17-23-15-26(32(46-37(23)59-39)49-9-12-57-13-10-49)45-36(56)29-30(48-52-8-4-6-42-34(29)52)28-20-50(11-14-58-28)33-27(16-24-18-40(2,22-54)60-38(24)47-33)44-35(55)25-19-43-51-7-3-5-41-31(25)51/h3-8,15-16,19,28,53-54H,9-14,17-18,20-22H2,1-2H3,(H,44,55)(H,45,56)/t28?,39-,40+/m1/s1 |
| InChIKey | VBQDPUZDPWMLNL-FKZXHRNRSA-N |
| XLogP | 1.85 |
| TPSA | 228.22 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 818.85 |
| LogP ≤ 5 | 1.85 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 18 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155063820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.